首頁 > 市場調查報告書 > 製藥

精神疾病

市場調查報告書

商品編碼

1539558

心理健康市場規模、佔有率和成長分析：按年齡層、服務、環境和地區 - 行業預測，2024-2031

Mental Health Market Size, Share, Growth Analysis, By Age Group, By Services, By Setting, By Region - Industry Forecast 2024-2031

出版日期: 2024年08月15日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球心理健康市場規模將為3,996.1億美元，從2023年的4,136億美元成長到2031年的5,446.3億美元，預計在預測期內（2024-2031年）複合年成長率為3.5%。

心理健康市場包括旨在預防、治療和管理心理健康障礙的廣泛產品和服務。該市場包括藥物、心理治療、數位健康解決方案和其他治療性介入，旨在為面臨心理健康挑戰的人提供有效且易於獲得的治療選擇。市場的首要目標是減輕個人、家庭和整個社會的精神疾病負擔。全球精神健康疾病的盛行率不斷上升，以及人們對精神健康問題的認知和接受程度不斷提高，正在推動該市場的成長。技術進步和研究也為創新治療方案（包括數位健康解決方案）鋪平了道路。然而，心理健康市場面臨重大挑戰，特別是圍繞精神疾病的恥辱感，這可能會阻止人們尋求治療。 COVID-19 大流行正在加劇現有的心理健康問題，並產生新的問題，例如壓力增加和社會孤立。雖然數位心理健康解決方案有好處，但它們也引起了人們對隱私和有效性的擔憂。此外，新問題也變得越來越重要，例如青少年心理健康、工作壓力以及氣候變遷對心理健康的影響。這些挑戰凸顯了持續創新和增加對心理健康舉措支持的必要性。

月經失調
- 憂鬱症
- 焦慮症
- 創傷後壓力症候群（PTSD）
- 躁鬱症
- 飲食障礙
- 藥物濫用
- 其他
精神障礙
- 思覺失調症
- 精神障礙
- 解離性障礙
- 強迫性精神官能症
- 注意力不足過動症（ADHD）
- 其他
行為障礙
- 自我傷害
- 侵略
- 睡眠障礙
- 退出社會
- 解離性障礙
- 過動症
- 其他
認知障礙
- 認知障礙
- 失智症
- 阿茲海默症
- 其他

心理健康市場：依技術分類

自我篩檢心理健康應用程式
遠端保健/虛擬護理解決方案
持續監控穿戴式裝置
基於人工智慧的篩檢工具
遠距心理健康平台

心理健康市場：依年齡段

兒童/青少年
成人
老年人

心理健康市場：依環境分類

臨床現場
教育機構
工作空間/企業計劃
網路平台
其他

心理健康市場規模：按地區分類

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Pfizer Inc.（US）
Johnson & Johnson（US）
Eli Lilly and Company（US）
Bristol-Myers Squibb（US）
GlaxoSmithKline（UK）
AstraZeneca（UK）
Merck & Co., Inc.（US）
Takeda Pharmaceutical Company Limited（Japan）
Otsuka Holdings Co., Ltd.（Japan）
Novartis International AG（Switzerland）
Sanofi SA（France）
Lundbeck A/S（Denmark）
Teva Pharmaceutical Industries Ltd.（Israel）
AbbVie Inc.（US）
Boehringer Ingelheim International GmbH（Germany）
H. Lundbeck A/S（Denmark）
Sun Pharmaceutical Industries Ltd.（India）
Alkermes plc（Ireland）
Amgen Inc.（US）
Gilead Sciences, Inc.（US）
Hikma Pharmaceuticals PLC（UK）
Jazz Pharmaceuticals plc（Ireland）

簡介目錄

Product Code: SQMIG35A2233

Global Mental Health Market size was valued at USD 399.61 billion in 2022 and is poised to grow from USD 413.60 billion in 2023 to USD 544.63 billion by 2031, at a CAGR of 3.5% during the forecast period (2024-2031).

The Mental Health Market encompasses a wide range of products and services designed to prevent, treat, and manage mental health disorders. This market includes pharmaceuticals, psychotherapy, digital health solutions, and other therapeutic interventions aimed at providing effective and accessible treatment options for those facing mental health challenges. The market's primary goal is to alleviate the burden of mental illness on individuals, families, and society as a whole. The increasing global prevalence of mental health disorders is a key driver of this market's growth, along with growing awareness and acceptance of mental health issues. Technological advancements and research have also paved the way for innovative treatment options, including digital health solutions. However, the mental health market faces significant challenges, particularly the stigma surrounding mental illness, which can deter individuals from seeking treatment. The COVID-19 pandemic has exacerbated existing mental health issues and introduced new ones, such as increased stress and social isolation. While digital mental health solutions offer benefits, they also raise concerns regarding privacy and effectiveness. Additionally, emerging issues like youth mental health, work-related stress, and the impact of climate change on mental health have become increasingly important. These challenges underscore the need for continued innovation and enhanced support for mental health initiatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Mental Health market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mental Health Market Segmental Analysis

The Mental Health Market is segmented based on Application, Screening Method, Technology, Age Group, Setting and region. Based on Application, the market is segmented into Physiological Disorder(Depression, Anxiety, Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder, Eating Disorder, Substance Abuse, Other Physiological Disorders), Psychiatric Disorders (Schizophrenia, Psychotic Disorder, Dissociative Disorder, Obsessive Compulsive Disorder, Dissociative Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Other Psychiatric Disorders), Behavioral Disorders(Self-Harm, Aggression, Sleep Disorder, Social Withdrawal, Dissociative Disorder, Hyperactivity, Other Behavioral Disorders), Cognitive Disorders(Cognitive Impairment, Dementia, Alzheimer's Disease, Other Cognitive Disorders), By Technology the market is segmented into Self Screening Mental Health Apps, Telehealth And virtual Care Solutions, Continuous Monitoring Wearable Devices, AI Based Screening Tools, Remote Mental Health Platforms , By Age Group, the market is segmented into Children And Adolescents, Adults, Seniors, By Setting the market is segmented into Clinical Setting Educational Institutions Workspace Slash Corporate Programs Online Platforms Other Settings, By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Mental Health Market

The increasing prevalence of mental health disorders, influenced by high-stress lifestyles, the lingering effects of COVID-19, and improved diagnostic methods, is driving the demand for mental health services. As public awareness campaigns gain momentum and stigma surrounding mental health diminishes, more individuals are encouraged to seek the help they need, contributing to the market's expansion. This growing recognition of mental health issues, combined with enhanced diagnostic capabilities, is leading to a surge in demand for mental health services. The positive shift in public perception, supported by awareness initiatives, is making it easier for people to seek treatment, thereby accelerating the growth of the mental health market.

Restraints in the Global Mental Health Market

The stigma surrounding mental illness remains a significant barrier to the utilization of mental health screening tools and resources. Despite ongoing efforts to reduce stigma and raise awareness, social misconceptions and negative attitudes about mental health persist, discouraging individuals from seeking help and using screening tools. A 2023 study by NAMI revealed that 44% of Americans with mental health conditions reported experiencing discrimination due to their diagnosis. Fear of judgment, unfair treatment, or negative consequences often leads individuals to delay screening and treatment, which can worsen symptoms and complicate the management of mental health conditions.

Market Trends of the Global Mental Health Market

Telemedicine has become a significant trend in the mental health market, offering remote services like teletherapy and telepsychiatry that can be accessed from anywhere via smartphones or computers. This approach enhances accessibility and convenience, especially for patients in rural or remote areas, and can also be more cost-effective than traditional in-person care. Companies like Teladoc Health and Amwell are at the forefront of providing these telemedicine services, making mental health support more widely available.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Degree Of Competition
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Pricing analysis
Value chain analysis
Regulatory Analysis
Technology Analysis
Ecosystem analysis
Patent Analysis

Mental Health Market by Application

Physiological Disorder
- Depression
- Anxiety
- Post-Traumatic Stress Disorder (PTSD)
- Bipolar Disorder
- Eating Disorder
- Substance Abuse
- Other Physiological Disorders
Psychiatric Disorders
- Schizophrenia
- Psychotic Disorder
- Dissociative Disorder
- Obsessive Compulsive Disorder
- Dissociative Disorder
- Attention Deficit Hyperactivity Disorder (ADHD)
- Other Psychiatric Disorders
Behavioral Disorders
- Self-Harm
- Aggression
- Sleep Disorder
- Social Withdrawal
- Dissociative Disorder
- Hyperactivity
- Other Behavioral Disorders
Cognitive Disorders
- Cognitive Impairment
- Dementia
- Alzheimer's Disease
- Other Cognitive Disorders

Mental Health Market by Technology

Self-Screening Mental Health Apps
Telehealth And virtual Care Solutions
Continuous Monitoring Wearable Devices
AI Based Screening Tools
Remote Mental Health Platforms

Mental Health Market by Age Group

Children And Adolescents
Adults
Seniors

Mental Health Market by Setting

Clinical Setting
Educational Institutions
Workspace/Corporate Programs
Online Platforms
Other Settings

Mental Health Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Otsuka Holdings Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lundbeck A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
H. Lundbeck A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alkermes plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gilead Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hikma Pharmaceuticals PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jazz Pharmaceuticals plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments